U.S. Should Build Up Antibody Therapy Supply, Ex-FDA Chief Says

The U.S. should be building up reserves of therapeutic antibodies now ahead of any potential approval or emergency use authorization to treat the coronavirus, said the former head of the U.S. Food and Drug Administration.